W81K00-26-Q-A048 AMENDMENT 0002 Integrated Immunoassay and Chemistry Analyzer Reagents and Consumables
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Solicitation Amendment W81K0026QA0480002
A. The purpose of this solicitation amendment is to provide answers to questions received from industry.
B. CLIN descriptions, PWS, and Period of Performance has been updated. See Q&A and revised PWS PDF attachments.
C. ATTTENTION: The delivery period for this requirement has changed. Reference Q&A 17. Due
to a glitch in our system, currently we are unable to update the delivery period. The delivery
period will be updated at the time of award. Delivery period has changed as described below:
Base Year: 1 April 2026 to 31 March 2027 TO: 1 April 2026 to 30 September 2026 (Six Months)
OY1: 1 April 2027 to 31 March 2028 TO: 1 October 2026 to 30 September 2027
OY2: 1 April 2028 to 31 March 2029 TO: 1 October 2027 to 30 September 2028
OY3: 1 April 2029 to 31 March 2030 TO: 1 October 2028 to 30 September 2029
OY4: 1 April 2030 to 31 March 2031 TO: 1 October 2029 to 30 September 2030
D. Other terms and conditions remain the same.